Seek Returns logo

MTD vs. PHG: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at MTD and PHG, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

MTD is a standard domestic stock, while PHG trades as New York Registered Shares, providing U.S. investors with a way to invest in the foreign-based company.

SymbolMTDPHG
Company NameMettler-Toledo International Inc.Koninklijke Philips N.V.
CountryUnited StatesNetherlands
GICS SectorHealth CareHealth Care
GICS IndustryLife Sciences Tools & ServicesHealth Care Equipment & Supplies
Market Capitalization26.57 billion USD26.57 billion USD
ExchangeNYSENYSE
Listing DateNovember 14, 1997March 17, 1980
Security TypeCommon StockNY Reg Shrs

Historical Performance

This chart compares the performance of MTD and PHG by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

MTD vs. PHG: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolMTDPHG
5-Day Price Return-2.48%2.03%
13-Week Price Return13.54%17.87%
26-Week Price Return-1.01%-0.04%
52-Week Price Return-9.39%-12.66%
Month-to-Date Return4.55%4.20%
Year-to-Date Return5.40%-1.35%
10-Day Avg. Volume0.13M0.96M
3-Month Avg. Volume0.18M1.81M
3-Month Volatility28.82%27.62%
Beta1.401.06

Profitability

Return on Equity (TTM)

MTD

1,675.84%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.55%
Median
6.22%
Q1
3.86%
Min
-6.95%

MTD’s Return on Equity of 1,675.84% is exceptionally high, placing it well beyond the typical range for the Life Sciences Tools & Services industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.

PHG

-0.18%

Health Care Equipment & Supplies Industry

Max
34.53%
Q3
19.38%
Median
9.52%
Q1
4.86%
Min
-7.58%

PHG has a negative Return on Equity of -0.18%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.

MTD vs. PHG: A comparison of their Return on Equity (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Net Profit Margin (TTM)

MTD

21.46%

Life Sciences Tools & Services Industry

Max
27.28%
Q3
16.17%
Median
7.24%
Q1
3.00%
Min
-3.05%

A Net Profit Margin of 21.46% places MTD in the upper quartile for the Life Sciences Tools & Services industry, signifying strong profitability and more effective cost management than most of its peers.

PHG

0.90%

Health Care Equipment & Supplies Industry

Max
23.34%
Q3
13.06%
Median
9.53%
Q1
5.96%
Min
-3.87%

Falling into the lower quartile for the Health Care Equipment & Supplies industry, PHG’s Net Profit Margin of 0.90% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.

MTD vs. PHG: A comparison of their Net Profit Margin (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Operating Profit Margin (TTM)

MTD

26.49%

Life Sciences Tools & Services Industry

Max
33.15%
Q3
19.34%
Median
13.02%
Q1
8.05%
Min
-4.38%

An Operating Profit Margin of 26.49% places MTD in the upper quartile for the Life Sciences Tools & Services industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

PHG

6.11%

Health Care Equipment & Supplies Industry

Max
29.44%
Q3
17.80%
Median
13.95%
Q1
8.73%
Min
-3.56%

PHG’s Operating Profit Margin of 6.11% is in the lower quartile for the Health Care Equipment & Supplies industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.

MTD vs. PHG: A comparison of their Operating Profit Margin (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Profitability at a Glance

SymbolMTDPHG
Return on Equity (TTM)1,675.84%-0.18%
Return on Assets (TTM)25.15%-0.08%
Net Profit Margin (TTM)21.46%0.90%
Operating Profit Margin (TTM)26.49%6.11%
Gross Profit Margin (TTM)59.94%43.85%

Financial Strength

Current Ratio (MRQ)

MTD

1.12

Life Sciences Tools & Services Industry

Max
4.76
Q3
2.77
Median
1.85
Q1
1.40
Min
0.43

MTD’s Current Ratio of 1.12 falls into the lower quartile for the Life Sciences Tools & Services industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

PHG

1.26

Health Care Equipment & Supplies Industry

Max
4.90
Q3
3.05
Median
2.14
Q1
1.49
Min
0.86

PHG’s Current Ratio of 1.26 falls into the lower quartile for the Health Care Equipment & Supplies industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

MTD vs. PHG: A comparison of their Current Ratio (MRQ) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Debt-to-Equity Ratio (MRQ)

MTD

81.23

Life Sciences Tools & Services Industry

Max
1.75
Q3
0.83
Median
0.41
Q1
0.18
Min
0.00

With a Debt-to-Equity Ratio of 81.23, MTD operates with exceptionally high leverage compared to the Life Sciences Tools & Services industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

PHG

0.81

Health Care Equipment & Supplies Industry

Max
1.49
Q3
0.71
Median
0.45
Q1
0.14
Min
0.00

PHG’s leverage is in the upper quartile of the Health Care Equipment & Supplies industry, with a Debt-to-Equity Ratio of 0.81. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.

MTD vs. PHG: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Interest Coverage Ratio (TTM)

MTD

15.60

Life Sciences Tools & Services Industry

Max
29.61
Q3
23.24
Median
6.07
Q1
2.18
Min
-14.08

MTD’s Interest Coverage Ratio of 15.60 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.

PHG

1.41

Health Care Equipment & Supplies Industry

Max
58.29
Q3
25.56
Median
9.06
Q1
3.60
Min
-28.92

In the lower quartile for the Health Care Equipment & Supplies industry, PHG’s Interest Coverage Ratio of 1.41 indicates a tighter cushion for servicing debt, suggesting less financial flexibility than many of its competitors.

MTD vs. PHG: A comparison of their Interest Coverage Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Financial Strength at a Glance

SymbolMTDPHG
Current Ratio (MRQ)1.121.26
Quick Ratio (MRQ)0.670.81
Debt-to-Equity Ratio (MRQ)81.230.81
Interest Coverage Ratio (TTM)15.601.41

Growth

Revenue Growth

MTD vs. PHG: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

MTD vs. PHG: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

MTD

0.00%

Life Sciences Tools & Services Industry

Max
1.80%
Q3
0.78%
Median
0.37%
Q1
0.00%
Min
0.00%

MTD currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

PHG

0.00%

Health Care Equipment & Supplies Industry

Max
4.05%
Q3
1.76%
Median
0.71%
Q1
0.00%
Min
0.00%

PHG’s Dividend Yield of 0.00% is consistent with its peers in the Health Care Equipment & Supplies industry, providing a dividend return that is standard for its sector.

MTD vs. PHG: A comparison of their Dividend Yield (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Dividend Payout Ratio (TTM)

MTD

0.00%

Life Sciences Tools & Services Industry

Max
156.00%
Q3
65.73%
Median
23.81%
Q1
0.00%
Min
0.00%

MTD has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

PHG

0.42%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
72.47%
Median
27.49%
Q1
0.00%
Min
0.00%

PHG’s Dividend Payout Ratio of 0.42% is within the typical range for the Health Care Equipment & Supplies industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

MTD vs. PHG: A comparison of their Dividend Payout Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Dividend at a Glance

SymbolMTDPHG
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.42%

Valuation

Price-to-Earnings Ratio (TTM)

MTD

32.53

Life Sciences Tools & Services Industry

Max
117.96
Q3
65.59
Median
37.26
Q1
27.51
Min
1.73

MTD’s P/E Ratio of 32.53 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

PHG

140.05

Health Care Equipment & Supplies Industry

Max
73.48
Q3
51.69
Median
34.31
Q1
25.74
Min
11.47

At 140.05, PHG’s P/E Ratio is exceptionally high, exceeding the typical maximum for the Health Care Equipment & Supplies industry. This suggests the stock may be significantly overvalued compared to its peers and implies high market expectations that could be difficult to meet.

MTD vs. PHG: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Price-to-Sales Ratio (TTM)

MTD

6.98

Life Sciences Tools & Services Industry

Max
12.46
Q3
6.70
Median
4.24
Q1
2.68
Min
0.73

MTD’s P/S Ratio of 6.98 is in the upper echelon for the Life Sciences Tools & Services industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

PHG

1.26

Health Care Equipment & Supplies Industry

Max
9.53
Q3
5.26
Median
3.39
Q1
2.13
Min
0.00

In the lower quartile for the Health Care Equipment & Supplies industry, PHG’s P/S Ratio of 1.26 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

MTD vs. PHG: A comparison of their Price-to-Sales Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Price-to-Book Ratio (MRQ)

MTD

1,299.40

Life Sciences Tools & Services Industry

Max
7.99
Q3
4.69
Median
3.30
Q1
1.88
Min
1.02

At 1,299.40, MTD’s P/B Ratio is at an extreme premium to the Life Sciences Tools & Services industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

PHG

1.89

Health Care Equipment & Supplies Industry

Max
10.85
Q3
5.98
Median
3.48
Q1
2.43
Min
0.69

PHG’s P/B Ratio of 1.89 is in the lower quartile for the Health Care Equipment & Supplies industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

MTD vs. PHG: A comparison of their Price-to-Book Ratio (MRQ) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Valuation at a Glance

SymbolMTDPHG
Price-to-Earnings Ratio (TTM)32.53140.05
Price-to-Sales Ratio (TTM)6.981.26
Price-to-Book Ratio (MRQ)1,299.401.89
Price-to-Free Cash Flow Ratio (TTM)31.8414.66